Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Mar'25
Sep'24
Mar'24
Sep'23
Net Sales
66.67
55.80
43.27
26.65
22.10
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
66.67
55.80
43.27
26.65
22.10
Raw Material Cost
0.00
0.00
0.00
0.00
0.00
Purchase of Finished goods
12.47
12.80
8.33
4.52
4.84
(Increase) / Decrease In Stocks
0.74
-0.67
0.46
-0.57
-0.14
Employee Cost
7.87
7.38
6.95
3.72
3.61
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
Other Expenses
13.87
14.87
12.22
8.51
6.70
Total Expenditure (Excl Depreciation)
34.94
34.38
27.96
16.18
15.01
Operating Profit (PBDIT) excl Other Income
31.73
21.42
15.31
10.47
7.09
Other Income
2.90
1.15
1.57
0.85
0.75
Operating Profit (PBDIT)
34.63
22.57
16.88
11.32
7.84
Interest
1.18
1.24
1.91
1.73
1.53
Exceptional Items
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
33.45
21.33
14.97
9.59
6.31
Depreciation
3.85
3.65
2.31
1.12
1.14
Profit Before Tax
29.59
17.68
12.66
8.47
5.17
Tax
1.24
-0.43
3.64
2.39
0.87
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
28.34
18.11
9.02
6.09
4.30
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
28.34
18.11
9.02
6.09
4.30
Share in Profit of Associates
0.29
-0.06
0.04
-0.04
-0.04
Minority Interest
-13.52
-9.05
-3.93
0.01
-0.01
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
15.11
9.01
5.12
6.06
4.24
Equity Capital
15.50
15.40
15.40
15.40
15.40
Face Value
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
76.59
0.00
0.00
Earnings per share (EPS)
9.75
5.85
3.32
3.94
2.75
Diluted Earnings per share
9.79
6.44
3.39
3.94
3.15
Operating Profit Margin (Excl OI)
47.59%
38.39%
35.38%
39.29%
32.08%
Gross Profit Margin
50.17%
38.23%
34.6%
35.98%
28.55%
PAT Margin
42.51%
32.46%
20.85%
22.85%
19.46%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2025 is 19.48% vs 28.96% in Mar 2025
Consolidate Net Profit
Growth in half year ended Sep 2025 is 67.70% vs 75.98% in Mar 2025
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2025 is 48.13% vs 39.91% in Mar 2025
Interest
Growth in half year ended Sep 2025 is -4.84% vs -35.08% in Mar 2025
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2025 has improved from Mar 2025
Compare Half Yearly Results Of Unihealth Hosp With
Figures in Cr
Consolidate Half Yearly Results
Change(INR)
Change(%)
Net Sales
66.67
0
66.67
Other Operating Income
0.00
0.00
0.00
Total Operating income
66.67
0
66.67
Raw Material Cost
0.00
0
0.00
Purchase of Finished goods
12.47
0
12.47
(Increase) / Decrease In Stocks
0.74
0
0.74
Employee Cost
7.87
0
7.87
Power Cost
0.00
0
0.00
Manufacturing Expenses
-0.01
0
-0.01
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
13.87
0.00
13.87
Total Expenditure (Excl Depreciation)
34.94
0
34.94
Operating Profit (PBDIT) excl Other Income
31.73
0.00
31.73
Other Income
2.90
0
2.90
Operating Profit (PBDIT)
34.63
0
34.63
Interest
1.18
0
1.18
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
33.45
0
33.45
Depreciation
3.85
0
3.85
Profit Before Tax
29.59
0
29.59
Tax
1.24
0
1.24
Provisions and contingencies
0.00
0
0.00
Profit After Tax
28.34
0
28.34
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
28.34
0
28.34
Share in Profit of Associates
0.29
0
0.29
Minority Interest
-13.52
0
-13.52
Other related items
0.00
0.00
0.00
Consolidated Net Profit
15.11
0
15.11
Equity Capital
15.50
0
15.50
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
9.75
0
9.75
Diluted Earnings per share
9.79
0
9.79
Operating Profit Margin (Excl OI)
47.59%
0%
0.00
47.59%
Gross Profit Margin
50.17%
0%
0.00
50.17%
PAT Margin
42.51%
0%
0.00
42.51%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 66.67 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 19.48% vs 28.96% in Mar 2025
Half Yearly - Consolidate Net Profit
Consolidate Net Profit 15.11 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 67.70% vs 75.98% in Mar 2025
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 31.73 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 48.13% vs 39.91% in Mar 2025
Half Yearly - Interest
Interest 1.18 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is -4.84% vs -35.08% in Mar 2025
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 47.59%
in Sep 2025Figures in %
Growth in half year ended Sep 2025 has improved from Mar 2025






